Discontinued — last reported Q2 '18
Deferred Tax Assets
Pfizer Deferred Tax Assets decreased by 2.7% to $2.40B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.1%, from $2.12B to $2.40B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows a downward trend with a -10.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests potential future tax savings, while a decrease may indicate the utilization of these assets or valuation allowances.
Detailed definition
These are assets on the balance sheet that represent future tax savings resulting from temporary differences between acc...
Peer comparison
Standard accounting item for large corporations with complex tax structures and international operations.
deferred_tax_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.16B | $328.00M | $349.00M | $655.00M | $558.00M | $616.00M | $1.02B | $1.07B | $1.23B | $1.13B | $640.00M | $931.00M | $2.23B | $2.16B | $2.12B | $2.26B | $2.48B | $2.47B | $2.40B |
| QoQ Change | — | -92.1% | +6.4% | +87.7% | -14.8% | +10.4% | +66.1% | +4.3% | +15.5% | -8.7% | -43.1% | +45.5% | +139.2% | -3.1% | -1.7% | +6.4% | +9.9% | -0.6% | -2.7% |
| YoY Change | — | — | — | — | -86.6% | +87.8% | +193.1% | +62.9% | +120.8% | +82.6% | -37.4% | -12.7% | +80.8% | +91.8% | +231.6% | +142.5% | +11.4% | +14.3% | +13.1% |
Deferred Tax Assets at Other Companies
Frequently Asked Questions
- What is Pfizer's deferred tax assets?
- Pfizer (PFE) reported deferred tax assets of $2.40B in Q4 2025.
- How has Pfizer's deferred tax assets changed year-over-year?
- Pfizer's deferred tax assets increased by 13.1% year-over-year, from $2.12B to $2.40B.
- What is the long-term trend for Pfizer's deferred tax assets?
- Over 5 years (2020 to 2025), Pfizer's deferred tax assets has grown at a -10.0% compound annual growth rate (CAGR), from $4.06B to $2.40B.
- What does deferred tax assets mean?
- Future tax benefits that the company expects to realize.